Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

5,6-Dichlorobenzimidazole riboside

5,6-Dichlorobenzimidazole riboside (DRB) is a nucleoside analog that inhibits several carboxyl-terminal domain kinases, including casein kinase II and cell cycle-dependent kinases (CDK) . 5, 6-dichlorobenzimidazole riboside has antitumor activity. 5, 6-dichlorobenzimidazole riboside can induce apoptosis[1][2][3][4][5][6][7].

Product Specifications

CAS Number

[53-85-0]

Product Name Alternative

DRB

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

Apoptosis; CDK

Type

Oligonucleotides

Related Pathways

Apoptosis; Cell Cycle/DNA Damage

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/5-6-dichlorobenzimidazole-riboside.html

Concentration

10mM

Purity

99.95

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C3=CC(Cl)=C(Cl)C=C3N=C2)O1

Molecular Formula

C12H12Cl2N2O4

Molecular Weight

319.14

Precautions

H302, H315, H319, H335

References & Citations

[1]Zandomeni RO. Kinetics of inhibition by 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole on calf thymus casein kinase II. Biochem J. 1989 Sep 1;262 (2) :469-73. |[2]Yankulov K, et al. The transcriptional elongation inhibitor 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole inhibits transcription factor IIH-associated protein kinase. J Biol Chem. 1995 Oct 13;270 (41) :23922-5. |[3]Rickert P, et al. Cyclin C/CDK8 and cyclin H/CDK7/p36 are biochemically distinct CTD kinases. Oncogene. 1999 Jan 28;18 (4) :1093-102. |[4]Schang LM. Cyclin-dependent kinases as cellular targets for antiviral drugs. J Antimicrob Chemother. 2002 Dec;50 (6) :779-92. |[5]te Poele RH, et al. RNA synthesis block by 5, 6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB) triggers p53-dependent apoptosis in human colon carcinoma cells. Oncogene. 1999 Oct 14;18 (42) :5765-72. |[6]Kuo YH, et al. 5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole (DRB) induces apoptosis in breast cancer cells through inhibiting of Mcl-1 expression. Sci Rep. 2023 Aug 3;13 (1) :12621|[7]Kissman H M, et al. Synthesis and biological properties of certain 5, 6-dichlorobenzimidazole ribosides. Journal of the American Chemical Society, 1957, 79 (5) : 1185-1188

Shipping Conditions

Blue Ice

Storage Conditions

-20°C, 3 years (Powder)

Scientific Category

Oligonucleotides

Clinical Information

No Development Reported

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

CYP51A1 antibody
MBS9407979-01 0.05 mL

CYP51A1 antibody

Ask
View Details
CYP51A1 antibody
MBS9407979-02 0.1 mL

CYP51A1 antibody

Ask
View Details
CYP51A1 antibody
MBS9407979-03 5x 0.1 mL

CYP51A1 antibody

Ask
View Details
Wnt10a sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat)
50444116 3x 1.0 µg

Wnt10a sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat)

Ask
View Details
caspase-1 (A19) Antibody
MBS440006-01 0.2 mg

caspase-1 (A19) Antibody

Ask
View Details
caspase-1 (A19) Antibody
MBS440006-02 5x 0.2 mg

caspase-1 (A19) Antibody

Ask
View Details